Inventor · disambiguated record
Nathalie Scholler
Also filed as: SCHOLLER NATHALIE · SCHOLLER NATHALIE B
22 granted patents·8 pending applications·600 citations·filing 1999–2023
96Inventor score
Files withUNIV PENNSYLVANIA11LAW CHE-LEUNG3PACIFIC NORTHWEST RES INST3GILEAD SCIENCES INC2STANFORD RES INST INT2
Top patents by PatentIndex Score
30 records- 0198US9272002B2Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targetingUNIV PENNSYLVANIA·Filed 2012·Granted Mar 1, 2016·75 cites·13 claims
- 0297US8535678B2Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disordersLAW CHE-LEUNG·Filed 2012·Granted Sep 17, 2013·77 cites·25 claims
- 0396US9422351B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2012·Granted Aug 23, 2016·44 cites·12 claims
- 0495US9708384B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2012·Granted Jul 18, 2017·28 cites·6 claims
- 0595US8609104B2Treatment of B-cell cancers with anti-CD70 antibody-drug conjugatesLAW CHE-LEUNG·Filed 2012·Granted Dec 17, 2013·27 cites·25 claims
- 0695US7662387B2Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disordersSEATTLE GENETICS·Filed 2004·Granted Feb 16, 2010·142 cites·29 claims
- 0794US9345785B2Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugatesLAW CHE-LEUNG·Filed 2009·Granted May 24, 2016·23 cites·34 claims
- 0894US9279008B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2014·Granted Mar 8, 2016·16 cites·2 claims
- 0994US6770445B1Methods and compositions for diagnosing carcinomasPACIFIC NORTHWEST RES INST·Filed 2000·Granted Aug 3, 2004·78 cites·3 claims
- 1091US10266580B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2017·Granted Apr 23, 2019·5 cites·4 claims
- 1184US7547681B2Surface receptor antigen vaccinesUNIV WASHINGTON·Filed 2004·Granted Jun 16, 2009·12 cites·11 claims
- 1284US6734172B2Surface receptor antigen vaccinesPACIFIC NORTHWEST RES INST·Filed 1999·Granted May 11, 2004·60 cites·7 claims
- 1382US10160809B2Anti-TEM1 antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2017·Granted Dec 25, 2018·3 cites·5 claims
- 1478US7795411B2Vectors for expressing in vivo biotinylated recombinant proteinsHUTCHINSON FRED CANCER RES·Filed 2007·Granted Sep 14, 2010·6 cites·15 claims
- 1576US11912753B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2021·Granted Feb 27, 2024·0 cites·14 claims
- 1671US10961288B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2019·Granted Mar 30, 2021·0 cites·9 claims
- 1768US11041012B2Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigensUNIV PENNSYLVANIA·Filed 2019·Granted Jun 22, 2021·0 cites·6 claims
- 1867US9556272B2Anti-TEM1 antibodies and uses thereofSCHOLLER NATHALIE·Filed 2010·Granted Jan 31, 2017·1 cites·18 claims
- 1967US2010183636A1Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disordersSEATTLE GENETICS INC·Filed 2009·Application pending·0 cites
- 2066US11078285B2Anti-TEM1 antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Aug 3, 2021·0 cites·5 claims
- 2162US10259849B2Isolated B7-H4 specific compositions and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Apr 16, 2019·0 cites·7 claims
- 2260US12281171B2Periostin antibodies and methods of using the sameBIOVENTURES LLC·Filed 2019·Granted Apr 22, 2025·0 cites·13 claims
- 2359US2023355796A1Combination therapy for treating trop-2 expressing cancersGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2458US2025249115A1Combination therapy for treating tumor antigen expressing cancersGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2556US7745159B2Methods and compositions for diagnosing carcinomasSCHOLLER NATHALIE B·Filed 2004·Granted Jun 29, 2010·3 cites·27 claims
- 2649US2003219436A1Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion proteinFiled 2002·Application pending·0 cites
- 2743US2017267755A1Isolated anti-mesothelin antibodies, conjugates and uses thereofSTANFORD RES INST INT·Filed 2017·Application pending·0 cites
- 2841US2020078455A1Mesothelin vaccine for ovarian cancer preventionSTANFORD RES INST INT·Filed 2018·Application pending·0 cites
- 2940US2011104675A1Methods and Compositions for Diagnosing CarcinomasPACIFIC NORTHWEST RES INST·Filed 2010·Application pending·0 cites
- 3037US2018002439A1Anti-mesothelin antibodies and uses thereofINSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE (INSERM)·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →